Biogen is buying anti-inflammatory drug startup RayThera for up to $1 billion
Colleen Cabi
·
2026-06-18
·
via Quartz
The deal adds multiple small-molecule anti-inflammatory drug candidates to Biogen's pipeline, with the lead a…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。